{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T15:49:55Z","timestamp":1773762595082,"version":"3.50.1"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Res Notes"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1756-0500-7-45","type":"journal-article","created":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T18:02:42Z","timestamp":1390240962000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Left ventricular hypertrophy among black hypertensive patients: focusing on the efficacy of angiotensin converting enzyme inhibitors"],"prefix":"10.1186","volume":"7","author":[{"given":"Gari Negeri","family":"Jaleta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esayas Kebede","family":"Gudina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wondim","family":"Getinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,1,20]]},"reference":[{"issue":"1","key":"2612_CR1","first-page":"1","volume":"1","author":"G Santulli","year":"2013","unstructured":"Santulli G: Epidemiology of cardiovascular disease in the 21st century: updated numbers and updated facts. JCvD. 2013, 1 (1): 1-2.","journal-title":"JCvD"},{"issue":"49","key":"2612_CR2","first-page":"866","volume":"107","author":"RE Schmieder","year":"2010","unstructured":"Schmieder RE: End organ damage in hypertension. Dtsch Arztebl Int. 2010, 107 (49): 866-873.","journal-title":"Dtsch Arztebl Int"},{"key":"2612_CR3","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1161\/01.HYP.35.2.580","volume":"35","author":"G Schillaci","year":"2000","unstructured":"Schillaci G, Verdecchia P, Porcellati C, Cuccurullo O, Cosco C, Perticone F: Continuous relation between left ventricular mass and cardiovascular risk in essential hypertension. Hypertension. 2000, 35: 580-586. 10.1161\/01.HYP.35.2.580.","journal-title":"Hypertension"},{"key":"2612_CR4","doi-asserted-by":"publisher","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","volume":"322","author":"D Levy","year":"1990","unstructured":"Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined Left ventricular mass in the Framingham Heart Study. N Engl J Med. 1990, 322: 1561-1566. 10.1056\/NEJM199005313222203.","journal-title":"N Engl J Med"},{"issue":"2","key":"2612_CR5","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.pcad.2009.05.002","volume":"52","author":"SM Artham","year":"2009","unstructured":"Artham SM, Lavie CJ, Milani RV, Patel DA, Verma A, Ventura HO: Clinical impact of left ventricular hypertrophy and implications for regression. Prog Cardiovasc Dis. 2009, 52 (2): 153-167. 10.1016\/j.pcad.2009.05.002.","journal-title":"Prog Cardiovasc Dis"},{"issue":"12","key":"2612_CR6","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1097\/HJH.0b013e328330b845","volume":"27","author":"M Bombelli","year":"2009","unstructured":"Bombelli M, Facchetti R, Carugo S, Madotto F, Arenare F, Quarti-Trevano F, et al: Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of office blood pressure values. J Hypertens. 2009, 27 (12): 2458-2564. 10.1097\/HJH.0b013e328330b845.","journal-title":"J Hypertens"},{"issue":"5","key":"2612_CR7","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ajh.2008.16","volume":"21","author":"LM Ruilope","year":"2008","unstructured":"Ruilope LM, Schmieder RE: Left ventricular hypertrophy and clinical outcomes in hypertensive patients. Am J Hypertens. 2008, 21 (5): 500-508. 10.1038\/ajh.2008.16.","journal-title":"Am J Hypertens"},{"issue":"4","key":"2612_CR8","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1053\/euhj.2001.2774","volume":"23","author":"CT Larsen","year":"2002","unstructured":"Larsen CT, Dahlin J, Blackburn H, Scharling H, Appleyard M, Sigurd B: Prevalence and prognosis of electrocardiographic left ventricular hypertrophy, ST segment depression and negative T-wave; the Copenhagen City Heart Study. Eur Heart J. 2002, 23 (4): 315-324. 10.1053\/euhj.2001.2774.","journal-title":"Eur Heart J"},{"issue":"6","key":"2612_CR9","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1097\/01.hjr.0000106836.97722.cf","volume":"10","author":"E Lonn","year":"2003","unstructured":"Lonn E, Mathew J, Pogue J, Johnstone D, Danisa K, Bosch J, et al: Relationship of electrocardiographic left ventricular hypertrophy to mortality and cardiovascular morbidity in high risk patients. Eur J Cardiovasc Prev Rehabil. 2003, 10 (6): 420-428.","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"5","key":"2612_CR10","doi-asserted-by":"publisher","first-page":"345","DOI":"10.7326\/0003-4819-114-5-345","volume":"114","author":"MJ Koren","year":"1991","unstructured":"Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH: Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med. 1991, 114 (5): 345-352. 10.7326\/0003-4819-114-5-345.","journal-title":"Ann Intern Med"},{"issue":"6pt 1","key":"2612_CR11","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/S0895-7061(01)01289-4","volume":"14","author":"C Cipriano","year":"2001","unstructured":"Cipriano C, Gosse P, Bemurat L, Mas D, Lemetayer P, N\u2019Tela G, Clementy J: Prognostic value of left ventricular mass and its evolution during treatment in the Bordeaux cohort of hypertensive patients. Am J Hypertens. 2001, 14 (6pt 1): 524-529.","journal-title":"Am J Hypertens"},{"issue":"1","key":"2612_CR12","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3901\/JME.2012.16.021","volume":"125","author":"SX Wang","year":"2012","unstructured":"Wang SX, Xue H, Zou YB, Sun K, Fu CY, Wang H, Hui RT: Prevalence and risk factors for left ventricular hypertrophy and left ventricular geometric abnormality in the patients with hypertension among Han Chinese. Chin Med J (Engl). 2012, 125 (1): 21-26.","journal-title":"Chin Med J (Engl)"},{"key":"2612_CR13","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1093\/eurjhf\/hfr071","volume":"13","author":"R Knoll","year":"2011","unstructured":"Knoll R, Iaccarino G, Tarone G, Hilfiker-Kleiner D, Bauersachs J, Leite-Moreira AD, et al: Towards a re-definition of \u2018cardiac hypertrophy\u2019 through a rational characterization of left ventricular phenotypes: a position paper of the Working Group \u2018Myocardial Function\u2019 of the ESC. Eur J Heart Fail. 2011, 13: 811-819. 10.1093\/eurjhf\/hfr071.","journal-title":"Eur J Heart Fail"},{"issue":"10","key":"2612_CR14","first-page":"183","volume":"6","author":"AA Adebiyi","year":"2006","unstructured":"Adebiyi AA, Ogah OS, Aje A, Ojji DB, Adebayo AK, Oladapo OO, et al: Echocardiographic partition values and prevalence of left ventricular hypertrophy in hypertensive Nigerians. BMC Med Imaging. 2006, 6 (10): 183-188.","journal-title":"BMC Med Imaging"},{"issue":"3","key":"2612_CR15","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/HCO.0b013e3282fc27d9","volume":"23","author":"AJ Marian","year":"2008","unstructured":"Marian AJ: Genetic determinants of cardiac hypertrophy. Curr Opin Cardiol. 2008, 23 (3): 199-205. 10.1097\/HCO.0b013e3282fc27d9.","journal-title":"Curr Opin Cardiol"},{"key":"2612_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1161\/JAHA.112.001081","volume":"1","author":"G Santulli","year":"2012","unstructured":"Santulli G, Cipolletta E, Sorriento D, Del Giudice C, Anastasio A, Monaco S, et al: CaMK4 Gene deletion induces hypertension. J Am Heart Assoc. 2012, 1: 4-","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"2612_CR17","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40292-013-0001-8","volume":"20","author":"G Santulli","year":"2013","unstructured":"Santulli G, Trimarco B, Iaccarino G: GRK2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev. 2013, 20 (1): 5-12. 10.1007\/s40292-013-0001-8.","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"6 Suppl","key":"2612_CR18","doi-asserted-by":"publisher","first-page":"57B","DOI":"10.1016\/S0735-1097(85)80528-3","volume":"5","author":"S Oparil","year":"1985","unstructured":"Oparil S: Pathogenesis of ventricular hypertrophy. J Am Coll Cardiol. 1985, 5 (6 Suppl): 57B-65B.","journal-title":"J Am Coll Cardiol"},{"key":"2612_CR19","doi-asserted-by":"publisher","first-page":"8C","DOI":"10.1016\/S0002-9149(96)00183-X","volume":"77","author":"IS Blaufarb","year":"1996","unstructured":"Blaufarb IS, Sonnenblick EH: The renin-angiotensin system in left ventricular remodeling. Am J Cardiol. 1996, 77: 8C-16C. 10.1016\/S0002-9149(96)00183-X.","journal-title":"Am J Cardiol"},{"key":"2612_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.pharmthera.2005.11.001","volume":"111","author":"F Brunner","year":"2006","unstructured":"Brunner F, Bras-Silva C, Cerdeira AS, Leite-Moreira AF: Cardiovascular endothelins: essential regulators of cardiovascular homeostasis. Pharmacol Ther. 2006, 111: 508-531. 10.1016\/j.pharmthera.2005.11.001.","journal-title":"Pharmacol Ther"},{"issue":"2","key":"2612_CR21","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1161\/HYPERTENSIONAHA.113.02382","volume":"63","author":"G Santulli","year":"2014","unstructured":"Santulli G: Adrenal signaling in heart failure: something more than a distant ship\u2019s smoke on the horizon. Hypertension. 2014, 63 (2): 215-216.","journal-title":"Hypertension"},{"key":"2612_CR22","doi-asserted-by":"publisher","first-page":"3322","DOI":"10.1073\/pnas.031371998","volume":"98","author":"LJ De Windt","year":"2001","unstructured":"De Windt LJ, Lim HW, Bueno OF, Liang Q, Delling U, Braz JC, et al: Targeted inhibition of calcineurin attenuates cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A. 2001, 98: 3322-27. 10.1073\/pnas.031371998.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2612_CR23","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1006\/jmcc.2002.2011","volume":"34","author":"Q Liang","year":"2002","unstructured":"Liang Q, Molkentin JD: Divergent signaling pathways converge on gata4 to regulate cardiac hypertrophic gene expression. J Mol Cell Cardiol. 2002, 34: 611-16. 10.1006\/jmcc.2002.2011.","journal-title":"J Mol Cell Cardiol"},{"key":"2612_CR24","doi-asserted-by":"publisher","first-page":"H20","DOI":"10.1152\/ajpheart.00082.2005","volume":"289","author":"S Gupta","year":"2005","unstructured":"Gupta S, Young D, Sen S: Inhibition of NF-\u03baB induces regression of cardiac hypertrophy, independent of blood pressure control, in sponta-neously hypertensive rats. Am J Physiol Heart Circ Physiol. 2005, 289: H20-H29. 10.1152\/ajpheart.00082.2005.","journal-title":"Am J Physiol Heart Circ Physiol"},{"issue":"4","key":"2612_CR25","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1161\/HYPERTENSIONAHA.110.155960","volume":"56","author":"D Sorriento","year":"2010","unstructured":"Sorriento D, Santulli G, Fusco A, Anastasio A, Trimarco B, Iaccarino G: Intracardiac injection of AdGRK5-NT reduces left ventricular hypertrophy by inhibiting NF-kappaB-dependent hypertrophic gene expression. Hypertension. 2010, 56 (4): 696-704. 10.1161\/HYPERTENSIONAHA.110.155960.","journal-title":"Hypertension"},{"key":"2612_CR26","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/bmj.311.7000.273","volume":"311","author":"J Chamber","year":"1995","unstructured":"Chamber J: Left ventricular hypertrophy. BMJ. 1995, 311: 273-4. 10.1136\/bmj.311.7000.273.","journal-title":"BMJ"},{"key":"2612_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1161\/CIRCOUTCOMES.110.960112","volume":"4","author":"PM Okin","year":"2011","unstructured":"Okin PM, Kjeldsen SE, Dahl\u00f6f B, Devereux RB: Racial differences in incident heart failure during antihypertensive therapy. Circ Cardiovasc Qual Outcomes. 2011, 4: 157-164. 10.1161\/CIRCOUTCOMES.110.960112.","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"20","key":"2612_CR28","doi-asserted-by":"publisher","first-page":"1592","DOI":"10.1001\/jama.1995.03520440046035","volume":"273","author":"Y Liao","year":"1995","unstructured":"Liao Y, Cooper RS, McGee DL, Mensah GA, Ghali JK: The relative effects of left ventricular hypertrophy, coronary artery disease, and ventricular dysfunction on survival among black adults. JAMA. 1995, 273 (20): 1592-7. 10.1001\/jama.1995.03520440046035.","journal-title":"JAMA"},{"key":"2612_CR29","doi-asserted-by":"publisher","first-page":"3","DOI":"10.3109\/08037051.2010.514713","volume":"20","author":"C Cuspidi","year":"2010","unstructured":"Cuspidi C, Negri F, Muiesan ML, et al: Prevalence and severity of echocardiographic left ventricular hypertrophy in hypertensive patients in clinical practice. Blood Press. 2010, 20: 3-9.","journal-title":"Blood Press"},{"issue":"5","key":"2612_CR30","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1161\/01.HYP.23.5.600","volume":"23","author":"G De Simone","year":"1994","unstructured":"De Simone G, Devereux RB, Roman MJ, Alderman MH, Laragh JH: Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension. 1994, 23 (5): 600-6. 10.1161\/01.HYP.23.5.600.","journal-title":"Hypertension"},{"issue":"6","key":"2612_CR31","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1161\/01.CIR.103.6.836","volume":"103","author":"J Sundstr\u00f6m","year":"2001","unstructured":"Sundstr\u00f6m J, Lind L, Vessby B, Andr\u00e9n B, Aro A, Lithell H: Dyslipidemia and an unfavourable fatty acid profile predict left ventricular Hypertrophy 20 years later. Circulation. 2001, 103 (6): 836-41. 10.1161\/01.CIR.103.6.836.","journal-title":"Circulation"},{"issue":"3","key":"2612_CR32","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S0735-1097(10)80189-5","volume":"17","author":"TA Manolio","year":"1991","unstructured":"Manolio TA, Levy D, Garrison RJ, Castelli WP, Kannel WB: Relation of alcohol intake to left ventricular mass: The Framingham heart study. J Am Coll Cardiol. 1991, 17 (3): 717-21. 10.1016\/S0735-1097(10)80189-5.","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"2612_CR33","doi-asserted-by":"publisher","first-page":"1440","DOI":"10.1016\/j.echo.2005.10.005","volume":"18","author":"RM Lang","year":"2005","unstructured":"Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, et al: Recommendations for chamber quantification: A report from the American Society of Echocardiography\u2019s Guidelines and Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr. 2005, 18 (12): 1440-63. 10.1016\/j.echo.2005.10.005.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"2612_CR34","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1097\/00004872-199917100-00016","volume":"17","author":"A Coca","year":"1999","unstructured":"Coca A, Gabriel R, de la Figuera M, Lopez-Sendon JL, Fernandez R, Sagastagoitia JD, et al: The impact of different echocardiographic diagnostic criteria on the prevalence of left ventricular hypertrophy in essential hypertension: The VITAE study. J Hypertens. 1999, 17 (10): 1471-80. 10.1097\/00004872-199917100-00016.","journal-title":"J Hypertens"},{"issue":"2","key":"2612_CR35","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1157\/13084641","volume":"59","author":"JV Lozano","year":"2006","unstructured":"Lozano JV, Red\u00f3n J, Cea-Calvo L, Fern\u00e1ndez-P\u00e9rez C, Navarro J, Bonet A, Gonz\u00e1lez-Esteban J: Left ventricular hypertrophy in the Spanish hypertensive population:the ERIC-HTA study. Rev Esp Cardiol. 2006, 59 (2): 136-42. 10.1157\/13084641.","journal-title":"Rev Esp Cardiol"},{"key":"2612_CR36","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1097\/01.hjh.0000420032.99199.45","volume":"30","author":"G Kaspruk","year":"2012","unstructured":"Kaspruk G, Mitchenko O, Romanov V: Left ventricular hypertrophy and cardiovascular risk factors at patients with arterial hypertension and metabolic syndrome. J Hypertens. 2012, 30: e61-e62.","journal-title":"J Hypertens"},{"key":"2612_CR37","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1111\/j.1540-8175.2008.00713.x","volume":"25","author":"FH Jafary","year":"2008","unstructured":"Jafary FH, Jafar TH: Disproportionately high risk of left ventricular hypertrophy in Indo-Asian women: a call for more studies. Echocardiography. 2008, 25: 812-19. 10.1111\/j.1540-8175.2008.00713.x.","journal-title":"Echocardiography"},{"issue":"5","key":"2612_CR38","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4103\/1947-2714.112481","volume":"5","author":"AE Adekunle","year":"2013","unstructured":"Adekunle AE, Adeseye AI, Adebayo OT, Olatayo AA, Joseph OO, Ayodele AR: Left ventricular mass formulae and prevalence rates of echocardiographic left ventricular hypertrophy in Nigerians with essential hypertension. N Am J Med Sci. 2013, 5 (5): 325-9. 10.4103\/1947-2714.112481.","journal-title":"N Am J Med Sci"},{"key":"2612_CR39","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/HYPERTENSIONAHA.107.107474","volume":"51","author":"E Gerdts","year":"2008","unstructured":"Gerdts E, Okin PM, De Simone G, Cramariuc D, Wachtell K, Boman K, Devereux RB: Gender differences in left ventricular structure and function during antihypertensive treatment: the Losartan Intervention for Endpoint Reduction in Hypertension Study. Hypertension. 2008, 51: 1109-1114. 10.1161\/HYPERTENSIONAHA.107.107474.","journal-title":"Hypertension"},{"issue":"1","key":"2612_CR40","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1161\/01.CIR.103.1.102","volume":"103","author":"V Palmieri","year":"2001","unstructured":"Palmieri V, Bella JN, Arnet DK, Liu JE, Oberman A, Schuck MY, et al: Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study. Circulation. 2001, 103 (1): 102-7. 10.1161\/01.CIR.103.1.102.","journal-title":"Circulation"},{"issue":"4","key":"2612_CR41","first-page":"931","volume":"21","author":"O Ito","year":"1991","unstructured":"Ito O, Okamoto M, Murakami Y, Nakayama R: Correlations between blood pressure, left ventricular hypertrophy, and left ventricular diastolic function in hypertensive patients. J Cardiol. 1991, 21 (4): 931-41.","journal-title":"J Cardiol"},{"issue":"5","key":"2612_CR42","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1177\/2047487312447845","volume":"20","author":"E Nardi","year":"2013","unstructured":"Nardi E, Palermo A, Mul\u00e8 G, Cusimano P, Cerasola G, Rini GB: Prevalence and predictors of left ventricular hypertrophy in patients with hypertension and normal electrocardiogram. Eur J Prev Cardiol. 2013, 20 (5): 854-61. 10.1177\/2047487312447845.","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"2612_CR43","first-page":"25","volume":"52","author":"NA Koziolova","year":"2012","unstructured":"Koziolova NA, Shatunova IM, Lazarev IA: Risk factors of development of left ventricular hypertrophy in patients with hypertensive disease with high compliance to treatment. Kardiologiia. 2012, 52 (4): 25-30.","journal-title":"Kardiologiia"},{"key":"2612_CR44","volume-title":"WHO Report on the Global Tobacco Epidemic. Country profile: Ethiopia","author":"World Health organization","year":"2011","unstructured":"World Health organization: WHO Report on the Global Tobacco Epidemic. Country profile: Ethiopia. 2011,http:\/\/www.who.int\/tobacco\/surveillance\/policy\/country_profile\/eth.pdf,"},{"issue":"2","key":"2612_CR45","first-page":"309","volume":"6","author":"VA Almazov","year":"2000","unstructured":"Almazov VA, Shlyakhto EV, Konrady AO, Macsimova TA, Zaharov DV, Rudomanov OG: Correlation of hypertensive cardiac remodelling: comparison of different antihypertensive therapies. Med Sci Monit. 2000, 6 (2): 309-13.","journal-title":"Med Sci Monit"},{"issue":"5","key":"2612_CR46","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.1097\/00005344-199006165-00026","volume":"16","author":"P Gosse","year":"1990","unstructured":"Gosse P, Roudaut R, Herrero G, Dallocchio M: Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy. J Cardiovasc Pharmacol. 1990, 16 (5): S145-50.","journal-title":"J Cardiovasc Pharmacol"},{"issue":"Suppl 2","key":"2612_CR47","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000167341","volume":"6","author":"B Trimarco","year":"1986","unstructured":"Trimarco B, Ricciardelli B, De Luca N, Cuocolo A, Volpe M, Lembo G, Condorelli M: Reversal of left ventricular hypertrophy following treatment with beta-blockers: experience with tertatolol. Am J Nephrol. 1986, 6 (Suppl 2): 94-9.","journal-title":"Am J Nephrol"},{"issue":"2","key":"2612_CR48","first-page":"139","volume":"62","author":"T George","year":"2010","unstructured":"George T, Ajit MS, Abraham G: Beta blockers & left ventricular hypertrophy regression. Indian Heart J. 2010, 62 (2): 139-42.","journal-title":"Indian Heart J"},{"issue":"1","key":"2612_CR49","doi-asserted-by":"publisher","first-page":"67","DOI":"10.2147\/vhrm.2008.04.01.67","volume":"4","author":"C Cuspidi","year":"2008","unstructured":"Cuspidi C, Negri F, Zanchetti A: Angiotensin II receptor blockers and cardiovascular protection: focus on left ventricular hypertrophy regression and atrial fibrillation prevention. Vasc Health Risk Manag. 2008, 4 (1): 67-73. 10.2147\/vhrm.2008.04.01.67.","journal-title":"Vasc Health Risk Manag"},{"issue":"6","key":"2612_CR50","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/j.jacc.2003.11.029","volume":"43","author":"S Julius","year":"2004","unstructured":"Julius S, Alderman MH, Beevers G, Dahl\u00f6f B, Devereux RB, Douglas JG, et al: Cardiovascular risk reduction in hypertensive black patients with left ventricular hypertrophy: the LIFE study. J Am Coll Cardiol. 2004, 43 (6): 1047-55. 10.1016\/j.jacc.2003.11.029.","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"2612_CR51","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/qjmed\/92.4.187","volume":"92","author":"CR Gibbs","year":"1999","unstructured":"Gibbs CR, Beevers DG, Lip GY: The management of hypertensive disease in black patients. QJM. 1999, 92 (4): 187-92. 10.1093\/qjmed\/92.4.187.","journal-title":"QJM"},{"issue":"7","key":"2612_CR52","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.jacc.2007.04.060","volume":"50","author":"S Bangalore","year":"2007","unstructured":"Bangalore S, Messerli FH, Kostis JB, Pepine CJ: Cardiovascular protection using beta-blockers. J Am Coll Cardiol. 2007, 50 (7): 563-572. 10.1016\/j.jacc.2007.04.060.","journal-title":"J Am Coll Cardiol"},{"key":"2612_CR53","doi-asserted-by":"publisher","first-page":"495349","DOI":"10.4061\/2011\/495349","volume":"2011","author":"RE Katholi","year":"2011","unstructured":"Katholi RE, Couri DM: Left ventricular hypertrophy: major risk factor in patients with hypertension: update and practical clinical applications. Int J Hypertens. 2011, 2011: 495349-","journal-title":"Int J Hypertens"},{"issue":"1","key":"2612_CR54","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1161\/01.HYP.25.1.92","volume":"25","author":"M Li\u00e8vre","year":"1995","unstructured":"Li\u00e8vre M, Gu\u00e9ret P, Gayet C, Roudaut R, Haugh MC, Delair S, Boissel JP: Ramipril-induced regression of left ventricular hypertrophy in treated hypertensive individuals. HYCAR Study Group. Hypertension. 1995, 25 (1): 92-7. 10.1161\/01.HYP.25.1.92.","journal-title":"Hypertension"}],"container-title":["BMC Research Notes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1756-0500-7-45.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T02:47:51Z","timestamp":1630550871000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcresnotes.biomedcentral.com\/articles\/10.1186\/1756-0500-7-45"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,1,20]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2612"],"URL":"https:\/\/doi.org\/10.1186\/1756-0500-7-45","relation":{},"ISSN":["1756-0500"],"issn-type":[{"value":"1756-0500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,20]]},"assertion":[{"value":"27 September 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 January 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"45"}}